287 related articles for article (PubMed ID: 31067690)
1. Sodium-Hydrogen Exchanger Isoform-1 Inhibition: A Promising Pharmacological Intervention for Resuscitation from Cardiac Arrest.
Gazmuri RJ; Radhakrishnan J; Ayoub IM
Molecules; 2019 May; 24(9):. PubMed ID: 31067690
[TBL] [Abstract][Full Text] [Related]
2. Adverse postresuscitation myocardial effects elicited by buffer-induced alkalemia ameliorated by NHE-1 inhibition in a rat model of ventricular fibrillation.
Lamoureux L; Radhakrishnan J; Mason TG; Kraut JA; Gazmuri RJ
J Appl Physiol (1985); 2016 Nov; 121(5):1160-1168. PubMed ID: 27633736
[TBL] [Abstract][Full Text] [Related]
3. Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury.
Wang S; Radhakrishnan J; Ayoub IM; Kolarova JD; Taglieri DM; Gazmuri RJ
J Appl Physiol (1985); 2007 Jul; 103(1):55-65. PubMed ID: 17431086
[TBL] [Abstract][Full Text] [Related]
4. AVE4454B--a novel sodium-hydrogen exchanger isoform-1 inhibitor--compared less effective than cariporide for resuscitation from cardiac arrest.
Radhakrishnan J; Kolarova JD; Ayoub IM; Gazmuri RJ
Transl Res; 2011 Feb; 157(2):71-80. PubMed ID: 21256459
[TBL] [Abstract][Full Text] [Related]
5. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide.
Gazmuri RJ; Ayoub IM; Hoffner E; Kolarova JD
Circulation; 2001 Jul; 104(2):234-9. PubMed ID: 11447092
[TBL] [Abstract][Full Text] [Related]
6. Basic biology and pharmacology of the cardiac sarcolemmal sodium/hydrogen exchanger.
Avkiran M
J Card Surg; 2003; 18 Suppl 1():3-12. PubMed ID: 12691374
[TBL] [Abstract][Full Text] [Related]
7. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.
Avkiran M
Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficiency of Na+/Ca2+ exchanger or Na+/H+ exchanger inhibition and their combination in reducing coronary reperfusion-induced arrhythmias.
Szepesi J; Acsai K; Sebok Z; Prorok J; Pollesello P; Levijoki J; Papp JG; Varro A; Toth A
J Physiol Pharmacol; 2015 Apr; 66(2):215-26. PubMed ID: 25903952
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin decreases myocardial cytoplasmic Na
Baartscheer A; Schumacher CA; Wüst RC; Fiolet JW; Stienen GJ; Coronel R; Zuurbier CJ
Diabetologia; 2017 Mar; 60(3):568-573. PubMed ID: 27752710
[TBL] [Abstract][Full Text] [Related]
10. Sodium ion/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischemia and reperfusion injury.
Levitsky J; Gurell D; Frishman WH
J Clin Pharmacol; 1998 Oct; 38(10):887-97. PubMed ID: 9807968
[TBL] [Abstract][Full Text] [Related]
11. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1.
Gazmuri RJ; Ayoub IM; Kolarova JD; Karmazyn M
Crit Care Med; 2002 Apr; 30(4 Suppl):S166-71. PubMed ID: 11940795
[TBL] [Abstract][Full Text] [Related]
12. The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention.
Karmazyn M; Sawyer M; Fliegel L
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):323-35. PubMed ID: 16101565
[TBL] [Abstract][Full Text] [Related]
13. Myocardial protection during resuscitation from cardiac arrest.
Gazmuri RJ; Ayoub IM; Kolarova J
Curr Opin Crit Care; 2003 Jun; 9(3):199-204. PubMed ID: 12771670
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation.
Gumina RJ; Daemmgen J; Gross GJ
Eur J Pharmacol; 2000 May; 396(2-3):119-24. PubMed ID: 10822064
[TBL] [Abstract][Full Text] [Related]
15. Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability.
Ayoub IM; Kolarova J; Yi Z; Trevedi A; Deshmukh H; Lubell DL; Franz MR; Maldonado FA; Gazmuri RJ
Circulation; 2003 Apr; 107(13):1804-9. PubMed ID: 12665493
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cardiac sarcolemmal Na+/H+ exchanger activity by endogenous ligands. Relevance to ischemia.
Avkiran M; Haworth RS
Ann N Y Acad Sci; 1999 Jun; 874():335-45. PubMed ID: 10415545
[TBL] [Abstract][Full Text] [Related]
17. Sarcolemmal Na+/H+ exchanger activity and expression in human ventricular myocardium.
Yokoyama H; Gunasegaram S; Harding SE; Avkiran M
J Am Coll Cardiol; 2000 Aug; 36(2):534-40. PubMed ID: 10933369
[TBL] [Abstract][Full Text] [Related]
18. Modification of intracellular calcium concentration in cardiomyocytes by inhibition of sarcolemmal Na+/H+ exchanger.
Saini HK; Dhalla NS
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2790-800. PubMed ID: 16861694
[TBL] [Abstract][Full Text] [Related]
19. Chronic inhibition of na(+)/h(+)-exchanger in the heart.
Baartscheer A
Curr Vasc Pharmacol; 2006 Jan; 4(1):23-9. PubMed ID: 16472174
[TBL] [Abstract][Full Text] [Related]
20. Activation of caspase-3 may not contribute to postresuscitation myocardial dysfunction.
Radhakrishnan J; Ayoub IM; Gazmuri RJ
Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1164-74. PubMed ID: 19234092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
